Good news in regards to the fight against breast cancer. Combination therapy with biologic drugs before surgery, tumor removal achieved in half the cases. This is the result of an investigation called Neo-ALTTO that has been developed in 130 centers in 26 countries and a population of 455 patients.
Women elected to develop this study were carriers of a tumor positive ErbB2/HER2, one of the most aggressive and worse prognosis and therefore at higher risk of mortality or relapse. This tumor affects 25% of patients with breast cancer and almost half of women younger than 40. (more…)